NEW YORK (GenomeWeb News) — Thermo Fisher Scientific today said synthetic antibody developer AbD Serotec will use its DyLight dyes as part of a collaborative agreement to develop a series of fluorescent reagents.
Under the agreement, Serotec, a subsidiary of MorphoSys, will develop and sell the resulting products through its catalog, Thermo said.
Thermo said its DyLight products are water soluble and provide high fluorescent intensity in various applications.
Serotec has a catalog of more than 10,000 research antibodies, and it develops monoclonal antibodies using its parent company’s HuCal technology.
Financial terms of the agreement were not disclosed.